Search Results - "disease modelling"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Disease modeling hypertrophic cardiomyopathy using CRISPR/Cas9 genome editing technology in human pluripotent stem cell-derived cardiomyocytes by Mosqueira, Diogo

    Published 2018
    Subjects: “…Hypertrophic cardiomyopathy; disease modelling; CRISPR/Cas9; genome-edited human pluripotent stem cell-cardiomyocytes; R453C-βMHC…”
    Get full text
  8. 8
  9. 9
  10. 10

    Drug-mediated shortening of action potentials in LQTS2 hiPSC-cardiomyocytes by Duncan, Gary, Firth, Karl S.A., George, Vinoj, Hoang, Minh Duc, Stainforth, Andrew, Smith, Godfrey, Denning, Chris

    Published 2017
    Subjects: “…Human induced pluripotent stem cells; Cardiomyocytes; Disease modelling; Long QT syndrome; Action 23 potentials; Electrophysiology; IKr; HERG; IKATP; PPAR delta; Ion channel drug agonists…”
    Get full text
  11. 11

    The effect of cigarette smoke extract and e-cigarette vape extract on extracellular vesicle production by human immune cells by Gomez, Nancy

    Published 2024
    Subjects: “…Extracellular vesicles; Inflammatory disease model; Peripheral blood mononuclear cells…”
    Get full text
  12. 12
  13. 13

    Comparative histopathological and transcriptomic evaluation of urologic cancer models by de Brot, Simone

    Published 2020
    Subjects: “…Urological cancer; Pre-clinical disease models; Animal models; Oncogenic mechanisms…”
    Get full text
  14. 14
  15. 15

    Cardiomyocytes from human pluripotent stem cells: from laboratory curiosity to industrial biomedical platform by Denning, Chris, Borgdorff, Viola, Crutchley, James, Firth, Karl S.A., George, Vinoj, Kalra, Spandan, Kondrashov, Alexander, Hoang, Minh Duc, Mosqueira, Diogo, Patel, Asha, Prodanov, Ljupcho, Rajamohan, Divya, Skarnes, William C., Smith, James G.W., Young, Lorraine E.

    Published 2016
    Subjects: “…Human embryonic stem cells; human induced pluripotent stem cells; cas9/CRISPR genome editing; cardiomyocytes; drug screening; disease modelling; maturation factors; muscular thin films; engineered heart tissue; automated scalability; high content platforms; calcium imaging; electrophysiology; mitochondria; contractility…”
    Get full text
  16. 16
  17. 17